Literature DB >> 21628773

Uncertainties in planned dose due to the limited voxel size of the planning CT when treating lung tumors with proton therapy.

Samuel España1, Harald Paganetti.   

Abstract

Dose calculation for lung tumors can be challenging due to the low density and the fine structure of the geometry. The latter is not fully considered in the CT image resolution used in treatment planning causing the prediction of a more homogeneous tissue distribution. In proton therapy, this could result in predicting an unrealistically sharp distal dose falloff, i.e. an underestimation of the distal dose falloff degradation. The goal of this work was the quantification of such effects. Two computational phantoms resembling a two-dimensional heterogeneous random lung geometry and a swine lung were considered applying a variety of voxel sizes for dose calculation. Monte Carlo simulations were used to compare the dose distributions predicted with the voxel size typically used for the treatment planning procedure with those expected to be delivered using the finest resolution. The results show, for example, distal falloff position differences of up to 4 mm between planned and expected dose at the 90% level for the heterogeneous random lung (assuming treatment plan on a 2 × 2 × 2.5 mm(3) grid). For the swine lung, differences of up to 38 mm were seen when airways are present in the beam path when the treatment plan was done on a 0.8 × 0.8 × 2.4 mm(3) grid. The two-dimensional heterogeneous random lung phantom apparently does not describe the impact of the geometry adequately because of the lack of heterogeneities in the axial direction. The differences observed in the swine lung between planned and expected dose are presumably due to the poor axial resolution of the CT images used in clinical routine. In conclusion, when assigning margins for treatment planning for lung cancer, proton range uncertainties due to the heterogeneous lung geometry and CT image resolution need to be considered.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21628773     DOI: 10.1088/0031-9155/56/13/007

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  9 in total

1.  Degradation of proton depth dose distributions attributable to microstructures in lung-equivalent material.

Authors:  Uwe Titt; Martin Sell; Jan Unkelbach; Mark Bangert; Dragan Mirkovic; Uwe Oelfke; Radhe Mohan
Journal:  Med Phys       Date:  2015-11       Impact factor: 4.071

2.  Site-specific range uncertainties caused by dose calculation algorithms for proton therapy.

Authors:  J Schuemann; S Dowdell; C Grassberger; C H Min; H Paganetti
Journal:  Phys Med Biol       Date:  2014-07-03       Impact factor: 3.609

Review 3.  Advances in the use of motion management and image guidance in radiation therapy treatment for lung cancer.

Authors:  Jason K Molitoris; Tejan Diwanji; James W Snider; Sina Mossahebi; Santanu Samanta; Shahed N Badiyan; Charles B Simone; Pranshu Mohindra
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

Review 4.  Range uncertainties in proton therapy and the role of Monte Carlo simulations.

Authors:  Harald Paganetti
Journal:  Phys Med Biol       Date:  2012-05-09       Impact factor: 3.609

5.  Comparing 2 Monte Carlo Systems in Use for Proton Therapy Research.

Authors:  Mark Newpower; Jan Schuemann; Radhe Mohan; Harald Paganetti; Uwe Titt
Journal:  Int J Part Ther       Date:  2019-05-03

6.  Methodology for analysis and reporting patterns of failure in the Era of IMRT: head and neck cancer applications.

Authors:  Abdallah S R Mohamed; David I Rosenthal; Musaddiq J Awan; Adam S Garden; Esengul Kocak-Uzel; Abdelaziz M Belal; Ahmed G El-Gowily; Jack Phan; Beth M Beadle; G Brandon Gunn; Clifton D Fuller
Journal:  Radiat Oncol       Date:  2016-07-26       Impact factor: 3.481

7.  3D-printable lung phantom for distal falloff verification of proton Bragg peak.

Authors:  Junichi Koketsu; Hiroaki Kumada; Kenta Takada; Hideyuki Takei; Yutaro Mori; Satoshi Kamizawa; Yuchao Hu; Hideyuki Sakurai; Takeji Sakae
Journal:  J Appl Clin Med Phys       Date:  2019-09       Impact factor: 2.102

8.  Effects of the Bragg peak degradation due to lung tissue in proton therapy of lung cancer patients.

Authors:  Kilian-Simon Baumann; Veronika Flatten; Uli Weber; Stefan Lautenschläger; Fabian Eberle; Klemens Zink; Rita Engenhart-Cabillic
Journal:  Radiat Oncol       Date:  2019-10-25       Impact factor: 3.481

9.  Pro-con of proton: Dosimetric advantages of intensity-modulation over passive scatter for thoracic malignancies.

Authors:  Ang Wei Jie; Laure Marignol
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2020-09-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.